Analysis of BCG vaccinations

  • Dorothy S. Price


  1. 1.

    104,697 BCG vaccinations are analysed. 4,112 of these persons were contacts. The period covers four years.

  2. 2.

    The over-all conversion rate was 97·25 per cent.

  3. 3.

    The duration of immunity is discussed.

  4. 4.

    Undesirable reactions numbered 16 (0·011 per cent.).

  5. 5.

    Tuberculous disease developed in 10 immunised individuals (0·0071 per cent.) with 1 death. Eleven further cases occurred in persons who were incubating tuberculous disease about the time of vaccination (0·0078 per cent.) with 4 deaths.

  6. 6.

    The vaccine, tuberculin tests, and technique employed are described.



  1. 1.
    Edwards and Tolderlund (1952).Bulletin of W. H. O. on BCG-vaccine studies.Google Scholar
  2. 1a.
    Edwards, Palmer and Magnus (1953).H. O. Monograph on BCG Vaccination,Google Scholar
  3. 2.
    Wallgren, Arvid (1950).Tuberculosis and other Problems of Paediatrics. Williams and Wilkins.Google Scholar
  4. 3.
    Price, D. S. (1952).Irish Jo. Med. Sci., No. 314, p. 88.Google Scholar
  5. 4.
    Report of National BCG Committee for the year ending December, 1952.Google Scholar
  6. 5.
    Anderson, H. and Belfrage, H. (1939).Acta Paed., 26.Google Scholar
  7. 6.
    Enell, H. (1951).Nordisk Medicin, 46, 1072.PubMedGoogle Scholar
  8. 7.
    Cowell, J. St. P. (1952).Irish Jo. Med. Sci., Nos. 320–21, p. 370.Google Scholar
  9. 8.
    Palmer, E. C. and Edwards, P. Q. (1953).B.M.J. i, 363.CrossRefGoogle Scholar
  10. 9.
    Wallgren, Arvid (1947).Calmette- Vaccination in Sweden. Published by the Swedish National Anti-Tuberculosis Association.Google Scholar

Copyright information

© Springer 1954

Authors and Affiliations

  • Dorothy S. Price

There are no affiliations available

Personalised recommendations